WHI-P97 is primarily used in research settings to study its potential as an inhibitor of specific kinases involved in cellular signaling pathways. It has shown promise in preclinical studies for targeting pathways associated with cancer, particularly in inhibiting cell proliferation and inducing apoptosis in certain cancer cell lines. Researchers are exploring its efficacy in combination therapies to enhance treatment outcomes. Additionally, WHI-P97 is being investigated for its role in modulating immune responses, which could have implications in autoimmune diseases and inflammation-related conditions. Its application remains largely experimental, with ongoing studies aimed at understanding its mechanism of action and therapeutic potential.